Safety & Efficacy of Pilocarpine Eye Solutions for Temporary Improvement of Near Vision in Presbyopic Adults
Completed · Phase 3 · Has a placebo group
Conditions studied: Presbyopia
In brief
Volunteer participants are evaluated for eligibility during a Screening Visit; those meeting study inclusion/exclusion criteria are scheduled for 3 treatment visits. At each treatment visit, 1 of the 3 study solutions is self-administered to both eyes. Afterwards, efficacy and safety assessments are performed over a 3-hour period.
Key facts
- Study ID
- NCT04657172
- Run by
- Eyenovia Inc.
- People needed
- 84
- Starts
- 2020-12-15
- Expected to finish
- 2021-03-26
- Last updated by the study team
- 2021-08-09
Who can join
Age: 40 and older, up to 60. Sex: any. Healthy volunteers: accepted.
Where it is running
- VISION-1 Study Site #21 — Azusa, California, United States
- VISION-1 Study Site #52 — Newport Beach, California, United States
- VISION-1 Study Site #54 — Fort Collins, Colorado, United States
- VISION-1 Study Site #53 — Orlando, Florida, United States
- VISION-1 Study Site #50 — New York, New York, United States
- VISION-1 Study Site #17 — High Point, North Carolina, United States
- VISION-1 Study Site #22 — Raleigh, North Carolina, United States
- VISION-1 Study Site #51 — Cranberry Township, Pennsylvania, United States
- VISION-1 Study Site #03 — San Antonio, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.